PHADIA AB
TaiwanSweden20 products registeredMar 18, 2015 – Dec 24, 2024
VerifiedTFDA · Taiwan Food and Drug Administration registry
20
Total products
20
Product types
20
Active products
Dec 2024
Latest registration
Company details
- Address
- RAPSGATAN 7P,P.O. BOX 6460,751 37, UPPSALA, SWEDEN
Regulatory footprint
Search PHADIA AB across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
Fadia Automation Instrument Series (Non-Sterile)
Registered: Dec 24, 2024 • Expires: Oct 31, 2026
- Risk Class
- Class 1
- AR
- PHADIA TAIWAN INC.
Phadia System (Non-Sterile)
Registered: Oct 01, 2021 • Expires: Oct 31, 2026
- Risk Class
- Class 1
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA Calprotectin 2 Calibrators
Registered: Nov 01, 2017 • Expires: Nov 01, 2027
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA Calprotectin Controls
Registered: Oct 19, 2017 • Expires: Oct 19, 2027
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA Thyroid Positive Controls
Registered: Aug 16, 2016 • Expires: Aug 16, 2026
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
ImmunoCAP Phadiatop Infant
Registered: Mar 21, 2016 • Expires: Mar 21, 2026
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA CCP Positive controls
Registered: Nov 26, 2015 • Expires: Nov 26, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
ImmunoCAP Quality Club ECP (Non-sterile)
Registered: Nov 19, 2015 • Expires: Nov 19, 2025
- Risk Class
- Class 1
- Type
- MD
- AR
- PHADIA TAIWAN INC.
ImmunoCAP Phadiatop
Registered: Nov 17, 2015 • Expires: Nov 17, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
ImmunoCAP Quality Club Total IgE (Non-sterile)
Registered: Nov 12, 2015 • Expires: Nov 12, 2025
- Risk Class
- Class 1
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA IgM Calibrators
Registered: Sep 01, 2015 • Expires: Sep 01, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
ImmunoCAP Specific IgE Negative Control
Registered: Aug 11, 2015 • Expires: Aug 11, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA ANCA/GBM Positive Controls
Registered: Aug 11, 2015 • Expires: Aug 11, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA RF Positive Controls
Registered: May 29, 2015 • Expires: May 29, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA APS Positive controls
Registered: May 22, 2015 • Expires: May 22, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
EliA ANA Positive Controls
Registered: May 07, 2015 • Expires: May 07, 2025
- Risk Class
- Class 2
- Type
- MD
- AR
- PHADIA TAIWAN INC.
ILIA IGG Corrective Reagent Group
Registered: Mar 26, 2015 • Expires: Mar 26, 2030
- Risk Class
- Class 2
- AR
- PHADIA TAIWAN INC.
Singularity IgE External Parts Tube Fluid (Not Sterile)
Registered: Mar 20, 2015 • Expires: Mar 20, 2030
- Risk Class
- Class 1
- AR
- PHADIA TAIWAN INC.
ILIA IGG/IGM/igA negative quality solution solution
Registered: Mar 18, 2015 • Expires: Mar 18, 2030
- Risk Class
- Class 2
- AR
- PHADIA TAIWAN INC.
IRIA IGA Calibration Reagent Group
Registered: Mar 18, 2015 • Expires: Mar 18, 2030
- Risk Class
- Class 2
- AR
- PHADIA TAIWAN INC.
About this profile
Explore comprehensive manufacturer profile for PHADIA AB based in Sweden through Pure Global AI's free Taiwan medical device database. This manufacturer has 20 products registered in Taiwan across 20 unique product categories. Their regulatory history spans from Mar 18, 2015 to Dec 24, 2024.
This page provides detailed insights including 5 recent product registrations, 5 most popular products with Fadia Automation Instrument Series (Non-Sterile) having 1 registrations, and 1 authorized representatives including PHADIA TAIWAN INC.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.